FRA:PHI1 • NL0000009538
The current stock price of PHI1.DE is 26.15 EUR. In the past month the price increased by 7.26%. In the past year, price increased by 7.17%.
ChartMill assigns a technical rating of 8 / 10 to PHI1.DE. When comparing the yearly performance of all stocks, PHI1.DE turns out to be only a medium performer in the overall market: it outperformed 63.07% of all stocks.
ChartMill assigns a fundamental rating of 3 / 10 to PHI1.DE. PHI1.DE has a bad profitability rating. Also its financial health evaluation is rather negative.
Over the last trailing twelve months PHI1.DE reported a non-GAAP Earnings per Share(EPS) of 1.56. The EPS increased by 12.45% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 5.02% | ||
| ROA | 3.32% | ||
| ROE | 8.17% | ||
| Debt/Equity | 0.63 |
30 analysts have analysed PHI1.DE and the average price target is 27.26 EUR. This implies a price increase of 4.25% is expected in the next year compared to the current price of 26.15.
For the next year, analysts expect an EPS growth of -2.32% and a revenue growth 2.83% for PHI1.DE
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| 1MDT | MEDTRONIC PLC | 16.15 | 108.279B | ||
| 2M6 | MEDTRONIC PLC | 15.71 | 105.356B | ||
| SHL | SIEMENS HEALTHINEERS AG | 15.52 | 46.056B | ||
| 1PHIA | KONINKLIJKE PHILIPS NV | 17.38 | 25.46B | ||
| PHIA | KONINKLIJKE PHILIPS NV | 17.49 | 25.238B | ||
| BIM | BIOMERIEUX | 18.78 | 10.948B | ||
| DIA | DIASORIN SPA | 16.57 | 3.745B | ||
| OBCK | OTTOBOCK SE & CO KGAA | 17.9 | 3.548B | ||
| AFX | CARL ZEISS MEDITEC AG - BR | 11.58 | 2.415B |
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the Frankfurt Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the European exchanges | Find stocks with similar Fundamental rating on the European exchanges | Find the competitors with the best technical ratings on the European exchanges | Find the competitors with the best fundamentals on the European exchanges | Find the competitors with the best valuation on the European exchanges | Find the competitors with the best dividend on the European exchanges | Find the competitors with the best analyst ratings on the European exchanges
Koninklijke Philips NV is a technology company, which engages in the healthcare, lighting, and consumer well-being markets. The company is headquartered in Eindhoven, Noord-Brabant and currently employs 67,035 full-time employees. The company went IPO on 2009-09-18. The firm's segments include Personal Health businesses, Diagnosis & Treatment businesses, Connected Care businesses and Other. The Personal Health businesses segment is engaged in the health continuum, delivering integrated, connected solutions that support healthier lifestyles and those living with chronic disease as well as oral healthcare and mother and child care support. The Diagnosis & Treatment businesses segment delivers precision medicine and treatment, and therapy. The Connected Care businesses segment provides consumers, care givers and clinicians with digital solutions that facilitate care by enabling precision medicine and population health management. The Other segment comprises such items, as innovation, emerging businesses, royalties, among others.
KONINKLIJKE PHILIPS NV
High Tech Campus 5
Eindhoven NOORD-BRABANT NL
Employees: 67035
Phone: 31205977777
Koninklijke Philips NV is a technology company, which engages in the healthcare, lighting, and consumer well-being markets. The company is headquartered in Eindhoven, Noord-Brabant and currently employs 67,035 full-time employees. The company went IPO on 2009-09-18. The firm's segments include Personal Health businesses, Diagnosis & Treatment businesses, Connected Care businesses and Other. The Personal Health businesses segment is engaged in the health continuum, delivering integrated, connected solutions that support healthier lifestyles and those living with chronic disease as well as oral healthcare and mother and child care support. The Diagnosis & Treatment businesses segment delivers precision medicine and treatment, and therapy. The Connected Care businesses segment provides consumers, care givers and clinicians with digital solutions that facilitate care by enabling precision medicine and population health management. The Other segment comprises such items, as innovation, emerging businesses, royalties, among others.
The current stock price of PHI1.DE is 26.15 EUR. The price increased by 1.2% in the last trading session.
PHI1.DE does not pay a dividend.
PHI1.DE has a ChartMill Technical rating of 8 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
30 analysts have analysed PHI1.DE and the average price target is 27.26 EUR. This implies a price increase of 4.25% is expected in the next year compared to the current price of 26.15.
The Revenue of KONINKLIJKE PHILIPS NV (PHI1.DE) is expected to grow by 2.83% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
KONINKLIJKE PHILIPS NV (PHI1.DE) will report earnings on 2026-05-06.